PMI$7.74-9.79%
Picard Medical, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: NYSE
Mkt Cap:$20.58M
Float & O/S:
Inst Own:
DilutionScan read 34 of Picard Medical, Inc.'s SEC filings and found 7 warrant series, 5 convertibles, 1 shelf registration, 4 S-1 registrations and 5 completed offerings on file for PMI. The latest dilution event on file is a securities exchange on Oct 22, 2026. Analysis updated Oct 24, 2026.
Signal8 Summary
PMI
Going-concern warning and negative runway
Snapshot
Picard Medical is a tiny medical device maker in severe financial distress. While FY 2025 revenue grew 12.5% to $4.9M, the business lost $27M and burned $15.7M in free cash flow. With only $7.5M in cash, the company has a negative cash runway of roughly 1.8 months.
What's Happening Right Now
- : Q2 revenue rose 39% year-over-year to $3.0 million while the net loss narrowed 16% to $5.7 million.
- : NYSE American accepted the company's plan to address stockholders' equity deficiencies, granting a compliance period through November 2027.
- : The company executed a 1-for-50 reverse stock split to regain compliance with NYSE American listing standards.
- : CEO Patrick Schnegelsberg stepped down and was replaced by Interim CEO Richard Fang.
- : Kuehn Law is investigating potential breaches of fiduciary duty related to an alleged fraudulent stock promotion scheme.
